Investigations by Italian authorities and others have found that NGOs funded by among others George Soros, are actively financing private ships to smuggle tens of thousands of illegal North African refugees into the EU via Southern Italy. The human trafficking is reportedly linked to ISIS smuggling networks. If confirmed by authorities, it could potentially open the NGOs to criminal charges .
The exchange of human organs for cash or any other “valuable consideration” (such as a car or a vacation) is illegal in every country except Iran. Nonetheless, international organ trafficking—mostly of kidneys, but also of half-livers, eyes, skin and blood—is flourishing; the World Health Organization estimates that one fifth of the 70,000 kidneys transplanted worldwide every year come from the black market.
ICMEC Board of Directors, 1999-2016
It is a trend for pharmaceutical companies to contract third parties to conduct their clinical trials in order to test their drugs. This trend is referred to as ‘outsourcing’, and the companies that carry out the work are called ‘contract research organizations’ (CROs). In addition, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low- and middle-income countries. This trend is called ‘offshoring’. It is widely agreed that the offshoring of clinical trials to these regions should be scrutinized from an ethical perspective because of the vulnerability of the trial population. What happens when offshoring is combined with outsourcing? Do additional ethical risks arise when clinical trials are contracted out? Virtually all pharmaceutical companies publicly declare that they test their drugs in accordance with the highest ethical guidelines, such as the Declaration of Helsinki. But how do pharmaceutical companies safeguard their commitments when they outsource clinical trial activities to CROs in poor regions? These are the central questions that are addressed in this report.
Medicines intended for the European market are increasingly tested on clinical trial participants outside the EU in low and middle income countries. Over the past years, SOMO and Wemos have collected extensive evidence of violations of ethical principles and guidelines in such trials. In this briefng paper, SOMO and Wemos provide the European Parliament, the European Commission and the European Medicines Agency (EMA) with policy recommendations to take their responsibility and address this problem.
The documents show that in 1996 Clinton approved the export of radiation hardened chip sets to China. The specialized chips are necessary for fighting a nuclear war. “Waivers may be granted upon a national interest determination,” states a Commerce Department document titled “U.S. Sanctions on China.”
U.S. agrees to sell supercomputer to China, officials say Administration aims to embrace, not isolate, Beijing
WASHINGTON — In a good-will gesture toward China, the Clinton administration has agreed to sell it a sophisticated $8 million supercomputer, senior administration officials said yesterday. The decision is part of the administration’s strategy to embrace, rather than isolate, China despite disagreements over human rights, weapons proliferation and trade. The Clinton administration is determined to grab an ever-larger share of China’s market, the fastest growing in the world, and reduce a trade deficit that could exceed that with Japan by the end of the decade.
The Clinton Administration notified Congress today that it had approved the export of technology to China to permit the launching of a communications satellite aboard a Chinese rocket next month. President Clinton said in a letter to Congress that the transfer would not harm national security or significantly improve China’s military capability in space. The President was required under a 1998 law to certify that all such technology exports are in the national interest.